Literature DB >> 28508218

Recovery of a Paramyxovirus, the Human Metapneumovirus, from Cloned cDNA.

B G van den Hoogen1, R A M Fouchier2.   

Abstract

Human metapneumovirus (HMPV), a single-stranded negative-sense RNA virus belonging to the family Paramyxoviridae, is associated with respiratory tract illness, primarily in young children and persons with underlying disease. Based on genetic and antigenic variation, HMPV strains are classified into two serotypes, with isolates NL/1/00 and NL/1/99 as prototypes for serotypes A and B, respectively. The development of plasmid-based reverse genetics systems for both serotypes has resulted in developments of a wide range of vaccine candidates against HMPV infection. The approach to virus rescue of HMPV is similar to that used for other paramyxoviruses, starting with mini-replicon assays for optimizations of the rescue protocols and subsequent replacement of the mini genome with a plasmid expressing the cDNA of the full-length viral RNA genome. Here, we provide detailed information on the reverse genetics systems for HMPV.

Entities:  

Keywords:  HMPV; Human metapneumovirus; Reverse genetics; Single-stranded negative RNA virus; Virus rescue

Mesh:

Substances:

Year:  2017        PMID: 28508218     DOI: 10.1007/978-1-4939-6964-7_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Development and optimization of a direct plaque assay for trypsin-dependent human metapneumovirus strains.

Authors:  Jiuyang Xu; Yu Zhang; John V Williams
Journal:  J Virol Methods       Date:  2018-05-25       Impact factor: 2.014

2.  Viral replicons as valuable tools for drug discovery.

Authors:  Holger Hannemann
Journal:  Drug Discov Today       Date:  2020-04-06       Impact factor: 7.851

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.